Upstream Bio (UPB) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for Upstream Bio (UPB).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | 1.03M (+53.73%) | 670K (-1.47%) | 680K (-27.66%) | 940K (+64.91%) | 570K (-6.56%) | 610K (0.00%) | 610K (+19.61%) | 510K (-20.31%) | 640K (-63.64%) | 1.76M (+183.87%) | 620K | - | - |
Operating Expenses | |||||||||||||
Research And Development | 37M (-8.96%) | 40M (+21.80%) | 33M (-12.91%) | 38M (+46.78%) | 26M (+18.51%) | 22M (+41.09%) | 15M (+9.67%) | 14M (+20.36%) | 12M (-51.31%) | 24M (+208.22%) | 7.79M | - | - |
Selling General And Administrative | 8.08M (+21.14%) | 6.67M (+20.40%) | 5.54M (-25.34%) | 7.42M (+9.44%) | 6.78M (+31.40%) | 5.16M (+26.78%) | 4.07M (+2.26%) | 3.98M (+0.51%) | 3.96M (-53.30%) | 8.48M (+281.98%) | 2.22M | - | - |
Operating Expenses | 45M (-4.68%) | 47M (+21.60%) | 39M (-14.93%) | 45M (+38.98%) | 33M (+20.98%) | 27M (+38.10%) | 20M (+8.03%) | 18M (+15.34%) | 16M (-51.83%) | 32M (+224.58%) | 10M | - | - |
Depreciation And Amortization | 50K (-64.29%) | 140K | - | - | 40K (-50.00%) | 80K | - | - | 10K (-83.33%) | 60K | - | - | - |
Operating Income | |||||||||||||
Operating Income | -43.61M (-5.54%) | -46.17M (+22.05%) | -37.83M (-14.70%) | -44.35M (+38.55%) | -32.01M (+21.62%) | -26.32M (+39.33%) | -18.89M (+7.70%) | -17.54M (+16.86%) | -15.01M (-51.16%) | -30.73M (+227.26%) | -9.39M | - | - |
Ebit | -43.61M (-5.54%) | -46.17M (+22.05%) | -37.83M (-14.70%) | -44.35M (+38.55%) | -32.01M (+21.62%) | -26.32M (+39.33%) | -18.89M (+7.70%) | -17.54M (+16.86%) | -15.01M (-40.27%) | -25.13M (+167.63%) | -9.39M (+269.69%) | -2.54M (-16.99%) | -3.06M |
EBITDA | -43.57M (-20.04%) | -54.49M (+61.45%) | -33.75M (-15.56%) | -39.97M (+25.02%) | -31.97M (-0.12%) | -32.01M (+100.19%) | -15.99M (+8.92%) | -14.68M (-2.13%) | -15.00M (-52.15%) | -31.35M (+911.29%) | -3.10M (+22.05%) | -2.54M (-16.99%) | -3.06M |
Other Income / Expenses | |||||||||||||
Interest Income | 3.05M (-16.44%) | 3.65M (-11.19%) | 4.11M (-7.22%) | 4.43M (-6.54%) | 4.74M (-6.69%) | 5.08M (+75.17%) | 2.90M (+0.69%) | 2.88M (+126.77%) | 1.27M (-51.89%) | 2.64M (+72.55%) | 1.53M | - | - |
Net Interest Income | 3.05M (-16.44%) | 3.65M (-11.19%) | 4.11M (-7.22%) | 4.43M (-6.54%) | 4.74M (-6.69%) | 5.08M (+75.17%) | 2.90M (+0.69%) | 2.88M (+126.77%) | 1.27M (-51.89%) | 2.64M (+72.55%) | 1.53M | - | - |
Other Non Operating Income | 3.02M (-82.15%) | 17M (+313.69%) | 4.09M (-6.62%) | 4.38M (-7.59%) | 4.74M (-68.32%) | 15M (+415.86%) | 2.90M (+1.40%) | 2.86M (-30.58%) | 4.12M (-78.96%) | 20M (+211.78%) | 6.28M | - | - |
Net Income | |||||||||||||
Net Income From Continuing Operations | -40.59M (-4.40%) | -42.46M (+25.81%) | -33.75M (-15.56%) | -39.97M (+46.57%) | -27.27M (+28.39%) | -21.24M (+32.83%) | -15.99M (+8.92%) | -14.68M (+34.80%) | -10.89M (-7.95%) | -11.83M (+281.61%) | -3.10M (+22.05%) | -2.54M (-16.99%) | -3.06M |
Net Income | -40.59M (-4.40%) | -42.46M (+25.81%) | -33.75M (-15.56%) | -39.97M (+46.57%) | -27.27M (+28.39%) | -21.24M (+32.83%) | -15.99M (+8.92%) | -14.68M (+34.80%) | -10.89M (-7.95%) | -11.83M (+281.61%) | -3.10M (+22.05%) | -2.54M (-16.99%) | -3.06M |
Comprehensive Income Net Of Tax | -41.02M (-71.29%) | -142.89M (+326.41%) | -33.51M (-16.39%) | -40.08M (+49.11%) | -26.88M (-57.23%) | -62.85M (+303.14%) | -15.59M (+5.98%) | -14.71M (+34.46%) | -10.94M (-46.69%) | -20.52M (+557.69%) | -3.12M | - | - |